Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

 

Category: Hematology

Letter to Editor: In Response to "Coagulopathy of Coronavirus Disease 2019"

From Critical Care Medicine. This Letter to the Editor is in response to the article "Coagulopathy of Coronavirus 2019" by Iba et a.

   Estimated Time: 03:21 min Anticoagulation, Coronavirus, COVID-19

Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019

From Critical Care Medicine. The authors reviewed thromboelastography studies in critically ill patients with coronavirus disease 2019 to characterize their coagulation states.

   Estimated Time: 23:34 min Coronavirus, COVID-19, Therapies

Which is better for anticoagulation in hospitalized non-ICU patients: low-molecular-weight heparin or oral anticoagulants?

In this question and answer webcast, attendees had the opportunity to post questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, w...

   Estimated Time: 00:51 min Coronavirus, COVID-19, Therapies

What are the differences between disseminated intravascular coagulation and coagulopathy in COVID-19 patients?

In this question and answer webcast, attendees had the opportunity to post questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, w...

   Estimated Time: 04:34 min Coronavirus, COVID-19, Therapies

What is the efficacy of convalescent plasma and what is the best way to use this therapy?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on June 10th, 2020.

   Estimated Time: 03:22 min Coronavirus, COVID-19, Therapies

Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients - A Proof-of-Principle Trial

This study describes a simple and safe protocol of anticoagulation with low molecular weight heparin (LMWH) in combination with bedside sustained low efficiency hemodialysis (SLED) in COVID-19 patients.

   Estimated Time: 09:16 min Anticoagulation, Coronavirus, COVID-19

Have you considered lymphopenia as a criterion to suspect COVID-19?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Gr...

   Estimated Time: 01:02 min Coronavirus, COVID-19, Diagnosis and Testing

What is your anticoagulation protocol in COVID-19 patients?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Gr...

   Estimated Time: 01:43 min Anticoagulation, Coronavirus, COVID-19

Is there a threshold for D-dimer or fibrinogen levels to determine therapeutic doses of anticoagulation without a definitive diagnosis of venous thromboembolism?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Gr...

   Estimated Time: 01:10 min Anticoagulation, Coronavirus, COVID-19

Coagulopathy of Coronavirus Disease 2019

From Critical Care Medicine. Recent studies have reported a high incidence of thrombotic events in COVID-19. However, the significance of thromboembolic complications has not been widely appreciated. The purpose of this review is to provide current knowledge of this serious pr...

   Estimated Time: 24:24 min Anticoagulation, Coronavirus, COVID-19, Therapies

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019

From Critical Care Medicine. The authors sought to determine the frequency of venous thromboembolism in critically ill coronavirus disease 2019 patients and associate a degree of inflammatory marker elevation to venous thromboembolism development. They found that routine chemi...

   Estimated Time: 24:31 min Coronavirus, COVID-19, Therapies

Anticoagulation Issues

This presentation covers treating anticoagulation issues seen in COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 15:41 min Anticoagulation, Coronavirus, COVID-19

Anticoagulation Issues in COVID-19

This presentation covers anticoagluation issues seen with COVID-19 patients. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 09:16 min Anticoagulation, Coronavirus, COVID-19

What is the recommended role of serial laboratory studies, including troponin, creatin kinase and D-dimer in the management of a hypercoagulable state?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

   Estimated Time: 02:11 min Anticoagulation, Clinical Trials, Coronavirus, COVID-19, Therapies

What is the latest research and level of evidence regarding convalescent plasma therapy?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

   Estimated Time: 07:25 min Coronavirus, COVID-19, Therapies